Xiongwei Xu

11PUBLICATIONS
3CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cross-sectional analysisHaematological tumoursBiologically active moleculesGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 25, 2026
Cost-effectiveness analysis of encorafenib in untreated BRAF V600E-mutant metastatic colorectal cancer in China.

|Apr 30, 2026
From budget constraints to value-based payment: an incremental cost-effectiveness analysis of sacituzumab tirumotecan for advanced triple-negative breast cancer in China.

|Feb 24, 2026
The pricing barrier: cost-effectiveness of Glofitamab for relapsed/refractory DLBCL in China beyond threshold and value-based pricing strategy considerations.

Shen Lin, Xiangzhen Wang, Lijing Yang

|Nov 07, 2025
Does the Combination of Anticoagulants and Angiogenesis Inhibitors Increase the Risk of Bleeding in Cancer Patients?

Qixin Chen, Xiaoting Huang, Shen Lin

|Jun 24, 2025
Small-Molecule Binding-Guided Nucleic Acid Amplification and Its Ultrasensitive Electrochemical Detection of Aflatoxin B1: A Split Aptamer Ligation Chain Reaction via Click Chemistry.

Jin-Yuan Chen, Jia-Yi Li, Liang-Yong Yang

|Sep 08, 2023
Precise Differentiation of Wobble-Type Allele via Ratiometric Design of a Ligase Chain Reaction-Based Electrochemical Biosensor for CYP2C19*2 Genotyping of Clinical Samples.

Zhou-Jie Liu, Liang-Yong Yang, Tai-Cheng Lu

Pageof 2

Frequent Collaborators

5 joint publications

Jin-Yuan Chen

4 joint publications

Xiuhua Weng

3 joint publications

Liang-Yong Yang